Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries

FIND, Unitaid support launch of diaTROPIX, Institut Pasteur de Dakar’s new regional diagnostics manufacturer advancing high-quality diagnostics for the continent and beyond

From promise to impact: Unlocking lenacapavir’s potential to end HIV

Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug

Preventing HIV-related deaths by optimizing advanced HIV disease management

The last mile in child medicine: The best HIV medicines for the youngest babies

COP29 spotlight: How Unitaid can reduce emissions in HIV treatment

Delivering a best-in-class HIV drug – three times faster